Physitrack

The company's IPO included around 4.4 million shares. 

A new study of 27,000 virtual physiotherapy patients has concluded that digital physiotherapy must become a significant part of the treatment mix post COVID-19.

Also: 23andMe gets FDA nod for direct-to-consumer test for hereditary colorectal cancer syndrome; Mobile Heartbeat announces integration with Imprivata. 

As providers around the globe continue rolling out digital health strategies, physician organizations are looking to implement guidelines. 

Also in deals this week: TeleDentist teams up with Call A Doctor Plus, and emergencey response app Twiage launched in Indianapolis hospital. 

To expand beyond the small- and mid-size employer market, digital physical therapy, telehealth, and patient engagement platform Physitrack has launched two new enterprise-focused offerings for new or current customers.